|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Donepudi MS, Kondapalli K, Amos SJ and
Venkanteshan P: Breast cancer statistics and markers. J Cancer Res
Ther. 10:506–511. 2014.PubMed/NCBI
|
|
3
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tan W, Yang M, Yang H, Zhou F and Shen W:
Predicting the response to neoadjuvant therapy for early-stage
breast cancer: Tumor-, blood-, and imaging-related biomarkers.
Cancer Manag Res. 10:4333–4347. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Salem Y, Yacov N, Propheta-Meiran O,
Breitbart E and Mendel I: Newly characterized motile sperm
domain-containing protein 2 promotes human breast cancer
metastasis. Int J Cancer. 144:125–135. 2019. View Article : Google Scholar
|
|
6
|
Kinsella MD, Nassar A, Siddiqui MT and
Cohen C: Estrogen receptor (ER), progesterone receptor (PR), and
HER2 expression pre- and post-neoadjuvant chemotherapy in primary
breast carcinoma: A single institutional experience. Int J Clin Exp
Pathol. 5:530–536. 2012.
|
|
7
|
Piao J, Chen L, Jin T, Xu M, Quan C and
Lin Z: Paip1 affects breast cancer cell growth and represents a
novel prognostic biomarker. Hum Pathol. 73:33–40. 2018. View Article : Google Scholar
|
|
8
|
Sandoo A, Kitas GD and Carmichael AR:
Breast cancer therapy and cardiovascular risk: Focus on
trastuzumab. Vasc Health Risk Manag. 11:223–228. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nabetani A, Koujin T, Tsutsumi C,
Haraguchi T and Hiraoka Y: A conserved protein, Nuf2, is implicated
in connecting the centromere to the spindle during chromosome
segregation: A link between the kinetochore function and the
spindle checkpoint. Chromosoma. 110:322–334. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu P, Chen X, Sun J, Bie P and Zhang LD:
siRNA-mediated knockdown against NUF2 suppresses pancreatic cancer
proliferation in vitro and in vivo. Biosci Rep. 35:
pii:e001702015.
|
|
11
|
Fu HL and Shao L: Silencing of NUF2
inhibits proliferation of human osteosarcoma Saos-2 cells. Eur Rev
Med Pharmacol Sci. 20:1071–1079. 2016.PubMed/NCBI
|
|
12
|
Xiang YJ, Fu Q, Ma ZB, Gao DZ, Zhang Q, Li
YY, Li L, Liu L, Ye CM, Yu ZG and Guo MM: Screening for candidate
genes related to breast cancer with cDNA microarray analysis.
Chronic Dis Transl Med. 1:65–72. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang W, Mao JH, Zhu W, Jain AK, Liu K,
Brown JB and Karpen GH: Centromere and kinetochore gene
misexpression predicts cancer patient survival and response to
radiotherapy and chemotherapy. Nat Commun. 7:126192016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Clarke C, Madden SF, Doolan P, Aherne ST,
Joyce H, O'Driscoll L, Gallagher WM, Hennessy BT, Moriarty M, Crown
J, et al: Correlating transcriptional networks to breast cancer
survival: A large-scale coexpression analysis. Carcinogenesis.
34:2300–2308. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gruosso T, Mieulet V, Cardon M, Bourachot
B, Kieffer Y, Devun F, Dubois T, Dutreix M, Vincent-Salomon A,
Miller KM and Mechta-Grigoriou F: Chronic oxidative stress promotes
H2AX protein degradation and enhances chemosensitivity in breast
cancer patients. EMBO Mol Med. 8:527–549. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Maubant S, Tesson B, Maire V, Ye M,
Rigaill G, Gentien D, Cruzalegui F, Tucker GC, Roman-Roman S and
Dubois T: Transcriptome analysis of Wnt3a-treated triple-negative
breast cancer cells. PLoS One. 10:e01223332015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee GY, Haverty PM, Li L, Kljavin NM,
Bourgon R, Lee J, Stern H, Modrusan Z, Seshagiri S, Zhang Z, et al:
Comparative oncogenomics identifies PSMB4 and SHMT2 as potential
cancer driver genes. Cancer Res. 74:3114–3126. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tomczak K, Czerwińska P and Wiznerowicz M:
The cancer genome atlas (TCGA): An immeasurable source of
knowledge. Contemp Oncol (Pozn). 19:A68–A77. 2015.
|
|
19
|
Pawitan Y, Bjohle J, Amler L, Borg AL,
Egyhazi S, Hall P, Han X, Holmberg L, Huang F, Klaar S, et al: Gene
expression profiling spares early breast cancer patients from
adjuvant therapy: Derived and validated in two population-based
cohorts. Breast Cancer Res. 7:R953–R964. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Buffa FM, Camps C, Winchester L, Snell CE,
Gee HE, Sheldon H, Taylor M, Harris AL and Ragoussis J:
microRNA-associated progression pathways and potential therapeutic
targets identified by integrated mRNA and microRNA expression
profiling in breast cancer. Cancer Res. 71:5635–5645. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
van de Vijver MJ, He YD, van't Veer LJ,
Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C,
Marton MJ, et al: A gene-expression signature as a predictor of
survival in breast cancer. N Engl J Med. 347:1999–2009. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jones SB, DePrimo SE, Whitfield ML and
Brooks JD: Resveratrol-induced gene expression profiles in human
prostate cancer cells. Cancer Epidemiol Biomarkers Prev.
14:596–604. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kao KJ, Chang KM, Hsu HC and Huang AT:
Correlation of microarray-based breast cancer molecular subtypes
and clinical outcomes: Implications for treatment optimization. BMC
Cancer. 11:1432011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The gene
ontology consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar
|
|
26
|
Dennis G Jr, Sherman BT, Hosack DA, Yang
J, Gao W, Lane HC and Lempicki RA: DAVID: Database for annotation,
visualization, and integrated discovery. Genome Biol. 4:P32003.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Doerks T, Copley RR, Schultz J, Ponting CP
and Bork P: Systematic identification of novel protein domain
families associated with nuclear functions. Genome Res. 12:47–56.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
30
|
Rhodes DR, Kalyana-Sundaram S, Mahavisno
V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ,
Kincead-Beal C, Kulkarni P, et al: Oncomine 3.0: Genes, pathways,
and networks in a collection of 18,000 cancer gene expression
profiles. Neoplasia. 9:166–180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xue D, Cheng P, Han M, Liu X, Xue L, Ye C,
Wang K and Huang J: An integrated bioinformatical analysis to
evaluate the role of KIF4A as a prognostic biomarker for breast
cancer. OncoTargets Ther. 11:4755–4768. 2018. View Article : Google Scholar
|
|
32
|
Chen L, Yuan L, Qian K, Qian G, Zhu Y, Wu
CL, Dan HC, Xiao Y and Wang X: Identification of biomarkers
associated with pathological stage and prognosis of clear cell
renal cell carcinoma by co-expression network analysis. Front
Physiol. 9:3992018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Du T, Sikora MJ, Levine KM, Tasdemir N,
Riggins RB, Wendell SG, Van Houten B and Oesterreich S: Key
regulators of lipid metabolism drive endocrine resistance in
invasive lobular breast cancer. Breast Cancer Res. 20:1062018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kaushik N, Kim S, Suh Y and Lee SJ:
Proinvasive extracellular matrix remodeling for tumor progression.
Arch Pharm Res. 42:40–47. 2019. View Article : Google Scholar
|
|
35
|
Walker C, Mojares E and Del Rio Hernández
A: Role of extracellular matrix in development and cancer
progression. Int J Mol Sci. 19:pii: E3028. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tilghman RW, Cowan CR, Mih JD, Koryakina
Y, Gioeli D, Slack-Davis JK, Blackman BR, Tschumperlin DJ and
Parsons JT: Matrix rigidity regulates cancer cell growth and
cellular phenotype. PLoS One. 5:e129052010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yao PL, Morales JL, Zhu B, Kang BH,
Gonzalez FJ and Peters JM: Activation of peroxisome
proliferator-activated receptor-β/δ (PPAR-β/δ) inhibits human
breast cancer cell line tumorigenicity. Mol Cancer Ther.
13:1008–1017. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Song W, Yan CY, Zhou QQ and Zhen LL:
Galangin potentiates human breast cancer to apoptosis induced by
TRAIL through activating AMPK. Biomed Pharmacother. 89:845–856.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shiraishi T, Terada N, Zeng Y, Suyama T,
Luo J, Trock B, Kulkarni P and Getzenberg RH: Cancer/testis
antigens as potential predictors of biochemical recurrence of
prostate cancer following radical prostatectomy. J Transl Med.
9:1532011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bagaria SP, Ray PS, Sim MS, Ye X, Shamonki
JM, Cui X and Giuliano AE: Personalizing breast cancer staging by
the inclusion of ER, PR, and HER2. JAMA Surg. 149:125–129. 2014.
View Article : Google Scholar
|
|
41
|
Ryu JM, Choi HJ, Kim I, Lee SK, Yu J, Kim
JE, Kang BI, Lee JE, Nam SJ and Kim SW: Only estrogen receptor
'positive' is not enough to predict the prognosis of breast cancer.
Breast Cancer Res Treat. 172:627–636. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Dunnwald LK, Rossing MA and Li CI: Hormone
receptor status, tumor characteristics, and prognosis: A
prospective cohort of breast cancer patients. Breast Cancer Res.
9:R62007. View Article : Google Scholar : PubMed/NCBI
|
